New Type 2 Diabetes Treatment, Adlyxin, Approved for Use in US
News, Type 2 Diabetes News
The U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide) as a new treatment for type 2 diabetes this week. The treatment consists of a daily injection that, combined with ... Read more